Journal of Applied Physiology, Vol 63, Issue 4 1434-1442, Copyright © 1987 by American Physiological Society

ARTICLES

Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity

B. A. Holm and R. H. Notter
Department of Biophysics (Toxicology) and Pediatrics (Neonatology), University of Rochester, New York 14642.

These experiments characterize the effects of hemoglobin and erythrocyte membrane lipids on the dynamic surface activity and adsorption facility of whole lung surfactant (LS) and a calf lung surfactant extract (CLSE) used clinically in surfactant replacement therapy for the neonatal respiratory distress syndrome (RDS). The results show that, at concentrations from 25 to 200 mg/ml, hemoglobin (Hb) increased the minimum dynamic surface tension of LS or CLSE mixtures (0.5 and 1.0 mumol/ml) from less than 1 to 25 dyn/cm on an oscillating bubble apparatus at 37 degrees C. Similarly, erythrocyte membrane lipids (0.5-3 mumol/ml) also prevented LS and CLSE suspensions (0.5-2.0 mumol/ml) from lowering surface tension below 19 dyn/cm under dynamic compression on the bubble. Surface pressure-time adsorption isotherms for LS suspensions (0.084 and 0.168 mumol phospholipid/ml) were also adversely affected by Hb (0.3-2.5 mg/ml), having a slower adsorption rate and magnitude. Significantly, these inhibitory effects of Hb and membrane lipids could be abolished if LS and CLSE concentrations were raised to high levels. In complementary physiological experiments, instillation of Hb, membrane lipids, or albumin into excised rat lungs was shown to cause a decrease in pressure-volume compliance. This decreased compliance was most prominent in lungs made partially surfactant deficient before inhibitor delivery and could be reversed by supplementation with active exogenous surfactant. Taken together, these data show that molecular components in hemorrhagic pulmonary edema can biophysically inactivate endogenous LS and adversely affect lung mechanics. Moreover, exogenous surfactant replacement can reverse this process even in the continued presence of inhibitor molecules and thus has potential utility in therapy for adult as well as neonatal RDS.

This article has been cited by other articles:

				Z. Wang, Y. Chang, A. L. Schwan, and R. H. Notter Activity and Inhibition Resistance of a Phospholipase-Resistant Synthetic Surfactant in Rat Lungs Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 387 - 394. [Abstract] [Full Text] [PDF]

				Z. Wang, A. Foye, Y. Chang, P. R. Chess, T. W. Wright, S. Bhagwat, F. Gigliotti, and R. H. Notter Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1124 - L1131. [Abstract] [Full Text] [PDF]

				A. Braun, M. Steinecker, S. Schumacher, and M. Griese Surfactant function in children with chronic airway inflammation J Appl Physiol, December 1, 2004; 97(6): 2160 - 2165. [Abstract] [Full Text] [PDF]

				M. Agassandian, S. N. Mathur, J. Zhou, F. J. Field, and R. K. Mallampalli Oxysterols Trigger ABCA1-Mediated Basolateral Surfactant Efflux Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 227 - 233. [Abstract] [Full Text] [PDF]

				Z. Wang, J. E. Baatz, B. A. Holm, and R. H. Notter Content-dependent activity of lung surfactant protein B in mixtures with lipids Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L897 - L906. [Abstract] [Full Text] [PDF]

				T. A. Russo, L. A. Bartholomew, B. A. Davidson, J. D. Helinski, U. B. Carlino, P. R. Knight III, M. F. Beers, E. N. Atochina, R. H. Notter, and B. A. Holm Total extracellular surfactant is increased but abnormal in a rat model of gram-negative bacterial pneumonia Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L655 - L663. [Abstract] [Full Text] [PDF]

				M Gupta, J M Hernandez-Juviel, A J Waring, and F J Walther Function and inhibition sensitivity of the N-terminal segment of surfactant protein B (SP-B1-25) in preterm rabbits Thorax, November 1, 2001; 56(11): 871 - 876. [Abstract] [Full Text] [PDF]

				T. W. Wright, R. H. Notter, Z. Wang, A. G. Harmsen, and F. Gigliotti Pulmonary Inflammation Disrupts Surfactant Function during Pneumocystis carinii Pneumonia Infect. Immun., February 1, 2001; 69(2): 758 - 764. [Abstract] [Full Text] [PDF]

				S. M. Wright, P. M. Hockey, G. Enhorning, P. Strong, K. B. M. Reid, S. T. Holgate, R. Djukanovic, and A. D. Postle Altered airway surfactant phospholipid composition and reduced lung function in asthma J Appl Physiol, October 1, 2000; 89(4): 1283 - 1292. [Abstract] [Full Text] [PDF]

				K. W. LU, H. WILLIAM TAEUSCH, B. ROBERTSON, J. GOERKE, and J. A. CLEMENTS Polymer-Surfactant Treatment of Meconium-induced Acute Lung Injury Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 623 - 628. [Abstract] [Full Text] [PDF]

				H. W. TAEUSCH, K. W. LU, J. GOERKE, and J. A. CLEMENTS Nonionic Polymers Reverse Inactivation of Surfactant by Meconium and Other Substances Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1391 - 1395. [Abstract] [Full Text] [PDF]

				K. A. Wong, A. Bano, A. Rigaux, B. Wang, B. Bharadwaj, S. Schurch, F. Green, J. E. Remmers, and S. U. Hasan Pulmonary vagal innervation is required to establish adequate alveolar ventilation in the newborn lamb J Appl Physiol, September 1, 1998; 85(3): 849 - 859. [Abstract] [Full Text] [PDF]

				Z. WANG and R. H. NOTTER Additivity of Protein and Nonprotein Inhibitors of Lung Surfactant Activity Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 28 - 35. [Abstract] [Full Text] [PDF]